ZA869501B - Sulfinyl and sulfonyl substituted-3-benzazepines - Google Patents

Sulfinyl and sulfonyl substituted-3-benzazepines

Info

Publication number
ZA869501B
ZA869501B ZA869501A ZA869501A ZA869501B ZA 869501 B ZA869501 B ZA 869501B ZA 869501 A ZA869501 A ZA 869501A ZA 869501 A ZA869501 A ZA 869501A ZA 869501 B ZA869501 B ZA 869501B
Authority
ZA
South Africa
Prior art keywords
c6alkyl
hydrogen
compounds
benzazepines
sulfinyl
Prior art date
Application number
ZA869501A
Other languages
English (en)
Inventor
William Edward Bondinell
Herbert Stowell Ormsbee Iii
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZA869501B publication Critical patent/ZA869501B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/16Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA869501A 1985-12-20 1986-12-18 Sulfinyl and sulfonyl substituted-3-benzazepines ZA869501B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/811,789 US4659706A (en) 1985-12-20 1985-12-20 Sulfinyl and sulfonyl substituted 3-benzazepines

Publications (1)

Publication Number Publication Date
ZA869501B true ZA869501B (en) 1987-08-26

Family

ID=25207582

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA869501A ZA869501B (en) 1985-12-20 1986-12-18 Sulfinyl and sulfonyl substituted-3-benzazepines

Country Status (17)

Country Link
US (1) US4659706A (fi)
EP (1) EP0229510B1 (fi)
JP (1) JPS62158255A (fi)
KR (1) KR870006007A (fi)
CN (1) CN86108627A (fi)
AT (1) ATE53385T1 (fi)
AU (1) AU589240B2 (fi)
CA (1) CA1263384A (fi)
DE (1) DE3671746D1 (fi)
DK (1) DK610686A (fi)
FI (1) FI865220A (fi)
HU (1) HUT43826A (fi)
IL (1) IL81006A0 (fi)
NO (1) NO865203L (fi)
PH (1) PH22358A (fi)
PT (1) PT83929B (fi)
ZA (1) ZA869501B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0285287A3 (en) * 1987-03-23 1990-08-16 Smithkline Beecham Corporation 3-benzazepine compounds for use in treating gastrointestinal motility disorders
AU1927992A (en) * 1991-06-21 1993-01-25 Smithkline Beecham Plc Medicaments
JP2002526443A (ja) 1998-09-18 2002-08-20 アルコン ラボラトリーズ, インコーポレーテッド 緑内障治療用セロトニン作動性5ht2作用物質
CA2347095A1 (en) * 1998-10-16 2000-04-27 Takeda Chemical Industries, Ltd. Nitrogen-containing condensed heterocyclic derivatives, their production and agent
KR100480782B1 (ko) * 2002-10-26 2005-04-07 삼성에스디아이 주식회사 연료전지 단위체, 그 제조방법 및 상기 연료전지 단위체를채용한 연료전지
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3483185A (en) * 1966-08-16 1969-12-09 American Home Prod N-substituted 2,3,4,5-tetrahydro-1h-3-benzazepines
CA974989A (en) * 1968-03-11 1975-09-23 Wallace And Tiernan Inc. Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby
DE1921737A1 (de) * 1969-04-29 1970-11-12 Bayer Ag Heterocyclische Acylreste enthaltende Sulfonylharnstoffe und Sulfonylsemicarbazide mit antidiabetischer Wirkung
US3671519A (en) * 1969-07-14 1972-06-20 American Home Prod N-substituted 2,3,4,5,-tetrahydro-1h-3-benzazepines
US3725388A (en) * 1970-06-25 1973-04-03 Boehringer Sohn Ingelheim N-acyl-7-(n{41 -cycloalkyl-ureido-n{40 -sulfonyl)-isoquinolines and -benzazepines and alkali metal salts thereof
CH593263A5 (fi) * 1974-02-22 1977-11-30 Hoffmann La Roche
US4206210A (en) * 1977-01-19 1980-06-03 Smithkline Corporation Alkylthio-7,8-dihdroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines having dopaminergic activity
US4265890A (en) * 1978-07-07 1981-05-05 Smithkline Corporation 6-Phenyl thio- and 6-cyclohexyl thio-2,3,4,5-tetrahydro-1H-3-benzazepines
US4469634A (en) * 1982-07-29 1984-09-04 Smithkline Beckman Corporation Allyloxy- and allylthio-2,3,4,5-tetrahydro-1H-3-benzazepines

Also Published As

Publication number Publication date
JPS62158255A (ja) 1987-07-14
DE3671746D1 (de) 1990-07-12
CA1263384A (en) 1989-11-28
FI865220A0 (fi) 1986-12-19
EP0229510A1 (en) 1987-07-22
PH22358A (en) 1988-08-12
AU589240B2 (en) 1989-10-05
PT83929B (pt) 1989-05-12
EP0229510B1 (en) 1990-06-06
PT83929A (en) 1987-01-01
US4659706A (en) 1987-04-21
FI865220A (fi) 1987-06-21
ATE53385T1 (de) 1990-06-15
DK610686D0 (da) 1986-12-17
DK610686A (da) 1987-06-21
KR870006007A (ko) 1987-07-08
NO865203D0 (no) 1986-12-19
CN86108627A (zh) 1987-07-22
IL81006A0 (en) 1987-03-31
AU6677986A (en) 1987-06-25
NO865203L (no) 1987-06-22
HUT43826A (en) 1987-12-28

Similar Documents

Publication Publication Date Title
PH25508A (en) Substituted quinazoline derivatives for use in gastrointestinal diseases
AU589240B2 (en) Sulfinyl and sulfonyl substituted-3-benzazepine
AU584235B2 (en) New tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing them
DK492989A (da) Aminopyrrolidinon, farmaceutisk praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling deraf
EP0302757A3 (en) Anti-emetic serotonin depleting agents
AU586724B2 (en) 1-phenyl-3-benzazepines
HUT71127A (en) 2,3,4,5-tetrahydro-1h-3-benzodiazepines and pharmaceutically acceptable acid additional salts thereof, pharmaceutical compositions containing them and process for their preparation
ZA88639B (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned
ES8802506A1 (es) Procedimiento para preparar derivados de fluoralcanos.
ES538171A0 (es) Procedimiento para la obtencion de un somnifero conteniendo lorazepam
NZ216741A (en) 6-oxo-1,6-dihydropyridazines and pharmaceutical compositions
AU577570B2 (en) Mefloquine quinates
PT82535A (en) Pharmacologically active propionylanilides
GB9926301D0 (en) Novel compounds